Categories AlphaGraphs, Earnings, Health Care
Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today.
Total revenue rose 1% year-over-year to $2.53 billion. Revenues grew 3% in constant currency.
Net loss attributable to Biogen Inc. was $68.1 million, or $0.47 per share, compared to income of $1.13 billion, or $7.84 per share, last year. Adjusted EPS decreased 9% to $4.36.
The company expects a low single digit percentage decline in total revenue for the full year of 2023 compared to the previous year. Adjusted EPS is expected to be $14.50-15.00.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
Key highlights from NIKE’s (NKE) Q2 2026 earnings results
NIKE, Inc. (NYSE: NKE) reported revenues of $12.4 billion for the second quarter of 2026, which were up 1% on a reported basis and flat on a currency-neutral basis compared
